Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...
Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.
A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...
HELLERUP, DENMARK, LONDON and KEELE, UK – 3 March 2025 – Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment ...
Additional investment and resources will accelerate Biocomposites' international expansion and innovation in products for use in infection management HELLERUP, Denmark, LONDON and KEELE ...
The Suffolk contamination control specialists constructed their first ever cleanroom 25 years ago – Director and founder Ray ...
A pioneering global manufacturer of brake and clutch components is driving innovation with the support of Bangor University.